Dublin, May 25, 2021 (GLOBE NEWSWIRE) – The “Medical Collagen Market Forecast to 2028 – Impact of COVID-19 and Global Analysis by Source, Product and Application” the report was added to ResearchAndMarkets.com from offer.

The medical collagen market is expected to reach 957.4 million by 2028 compared to US $ 593.7 million in 2020; it is expected to grow at a CAGR of 6.2% from 2021 to 2028. The market growth is mainly attributed to the increasing applications of collagen in the medical industry and the growing number of FDA approvals and product launches. However, product recalls are hampering market growth.

Various players operating in the medical collagen market are developing and launching new products to expand their geographic reach and ability to cater to many customers. For example, in April 2019, Collagen Matrix, Inc., a leading regenerative medicine company, manufacturing collagen and mineral-based medical devices, received 510 (k) approval from the Food and Drug Administration (FDA). from the United States for its innovative range of OssiMend mineral. Collagen composite moldable bioactive bone graft matrix.

Additionally, in 2018, Wright Medical Group NV received FDA approval for its AUGMENT Injectable Bone Grafting. It consists of a recombinant growth factor derived from human platelets and a mixture of type I collagen and beta-tricalcium phosphate.

Likewise, in 2016, the FDA approved Avedro’s corneal collagen cross-linking (CXL) to treat keratoconus and other types of corneal ectasia. Continuous product advancements and approvals of medical collagen products further drive the growth of medical collagen market.

Based on the application, the medical collagen market is segmented into hemostats, vascular grafts, tissue scaffolds, cartilage repair, wound care, bone grafts, diagnostics, and others. The wound care segment held the largest share of the market in 2020, and the bone grafts segment is expected to register the highest CAGR in the market during the forecast period. Some factors contributing to the growth of the market for wound care segment are the increasing prevalence of chronic diseases and conditions affecting the wound healing abilities, increasing funds for wound care research, number increasing traffic accidents and injuries and the increasing use of regenerative medicine in wound management.

The World Health Organization, the National Health Service, the Centers for Disease Control and Prevention, the Organization for Economic Co-operation and Development, the National Department of Health and the International Diabetes Federation as well as Company websites are among the primary and secondary sources referred to. Preparation of Medical Collagen Market report.

Reasons to buy

• Save time and reduce time in entry-level research by identifying growth, size, leading players and segments in the Medical Collagen market.
• Highlights key business priorities to help companies realign their business strategies.
• The key findings and recommendations highlight crucial progressive industry trends in the global Medical Collagen Market, thereby enabling value chain players to develop effective long term strategies.
• Develop / modify business expansion plans using substantial growth offering developed and emerging markets.
• Take an in-depth look at the global market trends and outlook, as well as the factors driving the market, as well as those hindering it.
• Improve the decision-making process by understanding the strategies that underpin the security interest in customer products, segmentation, pricing, and distribution.

Main topics covered:

1. Introduction

2. Medical Collagen Market – Key Points to Remember

3. Research methodology
3.1 Coverage
3.2 Secondary research
3.3 Primary research

4. Global Medical Collagen Market – Market Landscape
4.1 Overview
4.2 PEST analysis
4.2.1 Analysis of PESTs in North America
4.2.2 Analysis of PESTs in Europe
4.2.3 Analysis of PESTs in Asia-Pacific
4.2.4 Analysis of PESTs in the Middle East and Africa
4.2.5 Analysis of PESTs in South and Central America
4.3 Expert opinion

5. Medical Collagen Market – Industry Dynamics
5.1 Market factors
5.1.1 Growing Applications of Collagen in the Medical Industry
5.1.2 Increased FDA approvals and product launches
5.2 Market constraints
5.2.1 Product recalls
5.3 Market opportunities
5.3.1 Increasing disposable income and growing middle class population around the world
5.4 Future trends
5.4.1 Increase in research activities for collagen-based medical products
5.5 Impact analysis

6. Medical Collagen Market – Global Analysis
6.1 Global Medical Collagen Market Revenue Forecast and Analysis
6.2 Global Medical Collagen Market, By Geography – Forecast and Analysis
6.3 Market positioning of the main players

7. Medical Collagen Market Analysis – By Source
7.1 Overview
7.2 Medical Collagen Market Revenue Share, by Source (2020 and 2028)
7.3 Cattle
7.3.1 Overview
7.3.2 Bovine Medical Collagen Market Revenue and Forecast to 2028 (Million US $)
7.4 Pig
7.4.1 Overview
7.4.2 Porcine Medical Collagen Market Revenue and Forecast to 2028 (Million US $)
7.5 Others
7.5.1 Overview
7.5.2 Others: Medical Collagen Market Revenue and Forecast to 2028 (Million US $)

8. Medical Collagen Market Analysis – By Product
8.1 Overview
8.2 Medical Collagen Market Revenue Share, by Product (2020 and 2028)
8.3 Gelatin
8.3.1 Overview
8.3.2 Gelatin Medical Collagen Market Revenue and Forecast to 2028 (Million US $)
8.4 Hydrolyzed collagen
8.4.1 Overview
8.4.2 Hydrolyzed Collagen: Medical Collagen Market Revenue and Forecast to 2028 (USD Million) 8.4.2
8.5 Native collagen
8.5.1 Overview
8.5.2 Native Collagen: Medical Collagen Market Revenue and Forecast to 2028 (Million US $)
8.6 Other
8.6.1 Overview
8.6.2 Other: Medical Collagen Market Revenue and Forecast to 2028 (Million US $)

9. Medical Collagen Market – By Application
9.1 Overview
9.2 Medical Collagen Market, by Application, 2020 and 2028 (%)
9.3 Hemostats
9.3.1 Overview
9.3.2 Hemostats: Medical Collagen Market Revenue and Forecast to 2028 (Million US $)
9.4 Vascular grafts
9.4.1 Overview
9.4.2 Vascular Grafts: Medical Collagen Market – Revenue and Forecast to 2028 (USD Million)
9.5 Fabric scaffolds
9.5.1 Overview
9.5.2 Tissue Scaffolds: Medical Collagen Market – Revenue and Forecast to 2028 (USD Million) 9.5.
9.6 Repair of cartilage
9.6.1 Overview
9.6.2 Cartilage Repair: Medical Collagen Market Revenue and Forecast to 2028 (Million US $)
9.7 Wound care
9.7.1 Overview
9.7.2 Wound Care: Medical Collagen Market Revenue and Forecast to 2028 (Million US $)
9.8 Bone grafts
9.8.1 Overview
9.8.2 Bone Grafts Medical Collagen Market Revenue and Forecast to 2028 (Million US $)
9.9 Diagnostics
9.9.1 Overview
9.9.2 Diagnostics: Medical Collagen Market Revenue and Forecast to 2028 (USD Million)
9.10 Others
9.10.1 Overview
9.10.2 Others: Medical Collagen Market Revenue and Forecast to 2028 (USD Million)

10. Medical Collagen Market Analysis and Forecast to 2028 Geographic Analysis
10.1 North America: Medical Collagen Market
10.2 Europe: medical collagen market
10.3 Asia-Pacific: Medical Collagen Market
10.4 Middle East & Africa Medical Collagen Market
10.5 South and Central America: Medical Collagen Market

11. Impact of the COVID-19 pandemic on the global medical collagen market
11.1 North America: assessing the impact of the COVID-19 pandemic
11.2 Europe: assessment of the impact of the COVID-19 pandemic
11.3 Asia-Pacific: assessing the impact of the COVID-19 pandemic
11.4 Middle East and Africa: Assessment of the impact of the COVID-19 pandemic
11.5 South and Central America: Assessing the Impact of the COVID-19 Pandemic

12. Industry landscape
12.1 Overview
12.2 Growth strategies implemented by companies in the market, (%)
12.3 Organic developments
12.3.1 Overview
12.4 Inorganic developments
12.4.1 Overview

13. Company profiles
13.1 DSM
13.1.1 Key facts
13.1.2 Company description
13.1.3 Products and services
13.1.4 Financial overview
13.1.5 SWOT Analysis
13.1.6 Key developments
13.2 Collagen Solutions Plc
13.2.1 Key facts
13.2.2 Company description
13.2.3 Products and services
13.2.4 Financial overview
13.2.5 SWOT Analysis
13.2.6 Key developments
13.3 SYMATES
13.3.1 Key facts
13.3.2 Company description
13.3.3 Products and services
13.3.4 Financial overview
13.3.5 SWOT Analysis
13.3.6 Key developments
13.4 Innocoll pharmaceuticals
13.4.1 Key facts
13.4.2 Company description
13.4.3 Products and services
13.4.4 Financial overview
13.4.5 SWOT Analysis
13.4.6 Key developments
13.5 ENCOLL Corp.
13.5.1 Key facts
13.5.2 Company description
13.5.3 Products and services
13.5.4 Financial overview
13.5.5 SWOT Analysis
13.5.6 Key developments
13.6 CollPlant Biotechnology
13.6.1 Key facts
13.6.2 Company description
13.6.3 Products and services
13.6.4 Financial overview
13.6.5 SWOT Analysis
13.6.6 Key developments
13.7 GELITA AG
13.7.1 Key facts
13.7.2 Company description
13.7.3 Products and services
13.7.4 Financial overview
13.7.5 SWOT Analysis
13.7.6 Key developments
13.8 Collagen Matrix, Inc.
13.8.1 Key facts
13.8.2 Company description
13.8.3 Products and services
13.8.4 Financial overview
13.8.5 SWOT Analysis
13.8.6 Key developments
13.9 Integra Life Sciences Corporation
13.9.1 Key facts
13.9.2 Company description
13.9.3 Products and services
13.9.4 Financial overview
13.9.5 SWOT Analysis
13.9.6 Key developments
13.10 Croda International plc
13.10.1 Key facts
13.10.2 Company description
13.10.3 Products and services
13.10.4 Financial overview
13.10.5 SWOT Analysis
13.10.6 Key developments

14. Annex

For more information on this report, visit https://www.researchandmarkets.com/r/iyuv5